|
1
|
Giles IP, Pericleous C, Liu X, Ehsanullah J, Clarke L, Brogan P,
Newton-West M, Swerlick R, Lambrianides A, Chen P, Latchman D, Isenberg
D, Pierangeli S and Rahman A. Thrombin binding predicts the effects of
sequence changes in a human monoclonal antiphospholipid antibody on its
in vivo biologic actions. Journal of Immunology 2009; 182: 4836-43.
|
|
2
|
Rahman A, Isenberg DA, Systemic Lupus Erythematosus - Mechanisms of disease. New Eng J Med 2008; 358: 929-39.
|
|
3
|
Blair PA, Yassin Norena L, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR. Mauri C. CD19+CD24hiCD38hi B Cells Exhibit
Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in
Systemic Lupus Erythematosus Patients. Immunity 2010 32:1-12.
|
|
4
|
Giles I, Lambrianides N, Latchman D, Chen P, Chukwuocha R, Isenberg D
and Rahman A. The critical role of arginine residues in the binding of
human monoclonal antibodies to cardiolipin. Arthritis Research and Therapy 2005; 7: R47-R56.
|
|
5
|
Nadkarni
S, Mauri C, Ehrenstein MR. 2007. Anti-TNFα therapy induces a distinct
regulatory T cell population in patients with rheumatoid arthritis via TGFβ. J. Exp. Med. 204:33-9.
|
6
|
Edwards JCW, Cambridge G. B cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol 2006; 6(5): 394-403.
|
